Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Zeldis

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Hepatology (Baltimore, Md.)|July 1, 1988
In vitro hepatitis B virus suppression of erythropoiesis is dependent on the multiplicity of infection and is reversible with anti-HBs antibodiesJ B Zeldis, F A Farraye, H N Steinberg
British Journal of Cancer|October 14, 2005
Recent clinical studies of the immunomodulatory drug (IMiD) lenalidomideJ B Bartlett, A Tozer, D Stirling, et al.
Journal of Virology|June 1, 1990
In vitro inhibition of hemopoietic cell line growth by hepatitis B virusH S Steinberg, P Bouffard, C Trépo, et al.
Journal of Medical Virology|January 1, 1989
Inhibition of human hemopoiesis by non-A, non-B hepatitis virusJ B Zeldis, P J Boender, J A Hellings, et al.
Bone Marrow Transplantation|January 1, 1990
Fulminant hepatic failure following bone marrow transplantation for hepatitis-associated aplastic anemiaJ Van Dam, F A Farraye, R P Gale, et al.
Hepatology (Baltimore, Md.)|July 1, 1992
Chronic hepatitis B virus infection in an anti-HBc-nonreactive blood donor: variant virus or defective immune response?J H Lee, T G Paglieroni, P V Holland, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|January 1, 1995
Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescentsG M Schiff, J R Sherwood, J B Zeldis, et al.
Journal of Virological Methods|September 1, 1986
Correlation of HBV DNA and monoclonal reactivity to HBsAg in serum of patients with HBV infectionJ B Zeldis, E Ben-Porath, R Enat, et al.
Clinical Therapeutics|April 22, 1999
S.T.E.P.S.: a comprehensive program for controlling and monitoring access to thalidomideJ B Zeldis, B A Williams, S D Thomas, et al.
The Journal of Infectious Diseases|December 1, 1992
Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patientsP Bouffard, P H Hayashi, R Acevedo, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Hepatology (Baltimore, Md.)|July 1, 1988
In vitro hepatitis B virus suppression of erythropoiesis is dependent on the multiplicity of infection and is reversible with anti-HBs antibodiesJ B Zeldis, F A Farraye, H N Steinberg
British Journal of Cancer|October 14, 2005
Recent clinical studies of the immunomodulatory drug (IMiD) lenalidomideJ B Bartlett, A Tozer, D Stirling, et al.
Journal of Virology|June 1, 1990
In vitro inhibition of hemopoietic cell line growth by hepatitis B virusH S Steinberg, P Bouffard, C Trépo, et al.
Journal of Medical Virology|January 1, 1989
Inhibition of human hemopoiesis by non-A, non-B hepatitis virusJ B Zeldis, P J Boender, J A Hellings, et al.
Bone Marrow Transplantation|January 1, 1990
Fulminant hepatic failure following bone marrow transplantation for hepatitis-associated aplastic anemiaJ Van Dam, F A Farraye, R P Gale, et al.
Hepatology (Baltimore, Md.)|July 1, 1992
Chronic hepatitis B virus infection in an anti-HBc-nonreactive blood donor: variant virus or defective immune response?J H Lee, T G Paglieroni, P V Holland, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|January 1, 1995
Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescentsG M Schiff, J R Sherwood, J B Zeldis, et al.
Journal of Virological Methods|September 1, 1986
Correlation of HBV DNA and monoclonal reactivity to HBsAg in serum of patients with HBV infectionJ B Zeldis, E Ben-Porath, R Enat, et al.
Clinical Therapeutics|April 22, 1999
S.T.E.P.S.: a comprehensive program for controlling and monitoring access to thalidomideJ B Zeldis, B A Williams, S D Thomas, et al.
The Journal of Infectious Diseases|December 1, 1992
Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patientsP Bouffard, P H Hayashi, R Acevedo, et al.
Pageof 5